Elaborately engineering of a dual-drug co-assembled nanomedicine for boosting immunogenic cell death and enhancing triple negative breast cancer treatment.

Wang, Chen; Yu, Han; Yang, Xiaohong; Zhang, Xuanbo; Wang, Yuequan; Gu, Tianrui; Zhang, Shenwu; Luo, Cong

Wang, Chen; Yu, Han; Yang, Xiaohong; Zhang, Xuanbo; Wang, Yuequan; Gu, Tianrui; Zhang, Shenwu; Luo, Cong.

Afiliação

Wang C; Shenyang Pharmaceutical University, Shenyang 110016, China.
Yu H; Shenyang Pharmaceutical University, Shenyang 110016, China.
Yang X; Shenyang Pharmaceutical University, Shenyang 110016, China.
Zhang X; Shenyang Pharmaceutical University, Shenyang 110016, China.
Wang Y; Shenyang Pharmaceutical University, Shenyang 110016, China.
Gu T; Shenyang Pharmaceutical University, Shenyang 110016, China.
Zhang S; Shenyang Pharmaceutical University, Shenyang 110016, China.
Luo C; Shenyang Pharmaceutical University, Shenyang 110016, China.

Asian J Pharm Sci ; 17(3): 412-424, 2022 May.

Article em En | MEDLINE | ID: mdl-35782326

Palavras-chave

Carrier-free; Immune activation; Pure drug co-assembly; Synergistic chemo-photothermal therapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Asian J Pharm Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google